Literature DB >> 1467951

Cyclosporin A protects against ischemia-reperfusion injury in the brain.

Y Shiga1, H Onodera, Y Matsuo, K Kogure.   

Abstract

We investigated the protective effect of Cyclosporin A (CsA) against ischemia-reperfusion injury in the brain using a transient focal ischemia model in rats. In CsA-treated rats, ischemic brain edema formation 1 day after reperfusion in the cerebral cortex perfused by the middle cerebral artery (MCA) and infarct size were decreased compared with those in olive oil treated control rats. These results suggest that CsA is beneficial in reducing ischemia-reperfusion injury, possibly by the suppression of immunological reactions.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1467951     DOI： 10.1016/0006-8993(92)91465-q

Source DB:  PubMed          Journal:  Brain Res        ISSN： 0006-8993            Impact factor:   3.252


  29 in total

Review 1.  The future use of complement inhibitors for the treatment of neurological diseases.

Authors:  E G McGeer; P L McGeer
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

Review 2.  Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis.

Authors:  N Zamzami; T Hirsch; B Dallaporta; P X Petit; G Kroemer
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

3.  Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism.

Authors:  S P Butcher; D C Henshall; Y Teramura; K Iwasaki; J Sharkey
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

4.  Anesthetics isoflurane and desflurane differently affect mitochondrial function, learning, and memory.

Authors:  Yiying Zhang; Zhipeng Xu; Hui Wang; Yuanlin Dong; Hai Ning Shi; Deborah J Culley; Gregory Crosby; Edward R Marcantonio; Rudolph E Tanzi; Zhongcong Xie
Journal:  Ann Neurol       Date:  2012-02-24       Impact factor: 10.422

Review 5.  Mitochondrial Ca2+ and regulation of the permeability transition pore.

Authors:  Stephen Hurst; Jan Hoek; Shey-Shing Sheu
Journal:  J Bioenerg Biomembr       Date:  2016-08-06       Impact factor: 2.945

Review 6.  Trends and future developments in the pharmacological treatment of acute ischaemic stroke.

Authors:  G J del Zoppo; S Wagner; M Tagaya
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

7.  Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia.

Authors:  Anna C Schinzel; Osamu Takeuchi; Zhihong Huang; Jill K Fisher; Zhipeng Zhou; Jeffery Rubens; Claudio Hetz; Nika N Danial; Michael A Moskowitz; Stanley J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

8.  Dosing and safety of cyclosporine in patients with severe brain injury.

Authors:  Jimmi Hatton; Bonnie Rosbolt; Philip Empey; Richard Kryscio; Byron Young
Journal:  J Neurosurg       Date:  2008-10       Impact factor: 5.115

9.  Safety and tolerability of cyclosporin a in severe traumatic brain injury patients: results from a prospective randomized trial.

Authors:  Anna Teresa Mazzeo; Gretchen M Brophy; Charlotte B Gilman; Oscar Luís Alves; Jaime R Robles; Ronald L Hayes; John T Povlishock; M Ross Bullock
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

Review 10.  Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease.

Authors:  Rodrigo A Quintanilla; Gail V W Johnson
Journal:  Brain Res Bull       Date:  2009-07-19       Impact factor: 4.077
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.